Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Cited by (894)

Items 301–400 of 894

  1. Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
    Christopher Martin, Amy B. Criego, Anders L. Carlson, Richard M. Bergenstal · 2019 · Current Diabetes Reports
  2. A New Horizon for Glucose Monitoring
    Klemen Dovč, Nataša Bratina, Tadej Battelino · 2015 · Hormone Research in Paediatrics
  3. Use of Technology When Assessing Adherence to Diabetes Self-Management Behaviors
    Kimberly A. Driscoll, Deborah Lee Young-Hyman · 2014 · Current Diabetes Reports
  4. Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes
    Nalani Haviland, John S.A. Walsh, Ruth Roberts, Timothy Silleck Bailey · 2016 · Current Diabetes Reports
  5. Clinical Use of Continuous Glucose Monitoring in Pediatrics
    Rayhan Lal, David M. Maahs · 2017 · Diabetes Technology & Therapeutics
  6. Consensus and recommendations on continuous glucose monitoring
    Banshi Saboo, Manoj S Chawla, Sujeet Jha, Sudhir Bhandari, Prasanna K. M. Kumar, Jothydev Kesavadev, Yash Pal Munjal, Viswanathan Mohan, Ranjit Unnikrishnan I, Vishal Katswar et al. · 2018 · Journal of Diabetology
  7. Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients
    ANDREW R. LAVIK, Osagie A. Ebekozien, Nudrat Noor, Guy Todd Alonso, Sarit Polsky, Scott M. Blackman, Justin B. Chen, Sarah Dawn Corathers, Carla Demeterco‐Berggren, MARY PAT GALLAGHER et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  8. Predicting the Effectiveness of Insulin Pump Therapy on Glycemic Control in Clinical Practice: A Retrospective Study of Patients with Type 1 Diabetes from 10 Outpatient Diabetes Clinics in Sweden over 5 Years
    Mark Allen Clements, Viktorija Matuleviciene, Stig Attvall, Magnus Ekelund, Aldina Pivodic, Sofia Dahlqvist, Martin Fahlén, Börje S. Haraldsson, Marcus Lind · 2014 · Diabetes Technology & Therapeutics
  9. Technology Use in Transition-Age Patients With Type 1 Diabetes
    EVAN A. LOS, Jenae Ulrich, Ines Guttmann‐Bauman · 2016 · Journal of Diabetes Science and Technology
  10. Immune cell–adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes
    Fawaz Alzaïd, Guy Fagherazzi, Jean‐Pierre Riveline, Fatemah Bahman, Fatema Al‐Rashed, Fahd Al‐Mulla, Rasheed Ahmad · 2025 · Diabetologia
  11. Influence of a 3-year exercise intervention program on fracture risk, bone mass, and bone size in prepubertal children
    Bjarne Löfgren, Fredrik Detter, Magnus Dencker, Susanna Stenevi‐Lundgren, Jan‐Åke Nilsson, Magnus K. Karlsson · 2011 · Journal of Bone and Mineral Research
  12. Effect of Short-Term iPRO Continuous Glucose Monitoring on Hemoglobin A1c Levels in Clinical Practice
    Gary M. Pepper, Jamie Steinsapir, Kathryn Reynolds · 2012 · Diabetes Technology & Therapeutics
  13. Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis
    Su Lim Kang, Yoo Na Hwang, Ji Yean Kwon, Sung Min Kim · 2022 · Diabetology & Metabolic Syndrome
  14. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey
    Daniela Bruttomesso, Luigi Laviola, Giuseppe Lepore, Riccardo Bonfanti, Lutgarda Bozzetto, Emanuela Orsi, Vincenzo Di Blasi, Angela Girelli, Giorgio Grassi, Dario Iafusco et al. · 2014 · Diabetes Technology & Therapeutics
  15. Benefits of Short-Term Professional Continuous Glucose Monitoring in Clinical Practice
    Matthew C. Leinung, Elizabeth Nardacci, Nilem Patel, Shankar Bettadahalli, K Paika, Shannon Thompson · 2013 · Diabetes Technology & Therapeutics
  16. The rise of technology in diabetes care. Not all that is new is necessarily better
    Carlo L. Acerini · 2016 · Pediatric Diabetes
  17. Meta-Analysis of Overnight Closed-Loop Randomized Studies in Children and Adults with Type 1 Diabetes: The Cambridge Cohort
    Kavita Kumareswaran, Daniela Elleri, Janet M. Allen, Julie R. Harris, Dongyuan Xing, Craig Kollman, Marianna Nodale, Helen R. Murphy, Stephanie A. Amiel, Simon R. Heller et al. · 2011 · Journal of Diabetes Science and Technology
  18. Continuous Glucose Monitoring — Coming of Age
    Howard A. Wolpert · 2010 · New England Journal of Medicine
  19. Islet transplantation-immunological challenges and current perspectives
    Plamena Kabakchieva, Yavor S. Assyov, Stavros Gerasoudis, Georgi Vasilev, Monika Peshevska-Sekulovska, Metodija Sekulovski, Snezhina Lazova, Dimitrina Miteva, Milena Gulinac, L Tomov et al. · 2023 · World Journal of Transplantation
  20. Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis
    Shengsheng Yu, Biju Varughese, Zhiyi Li, Pam R. Kushner · 2018 · Diabetes Technology & Therapeutics
  21. Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis
    Rebecca Baqiyyah N. Conway, Andrea Gerard Gonzalez, Viral N. Shah, Cristy Geno Rasmussen, Halis Kaan Aktürk, Laura L. Pyle, Gregory P. Forlenza, Guy Todd Alonso, Janet K. Snell‐Bergeon · 2023 · Diabetes Metabolic Syndrome and Obesity
  22. In Vivo Performance and Biocompatibility of a Subcutaneous Implant for Real-Time Glucose-Responsive Insulin Delivery
    Michael K. L. Chu, Cláudia R. Gordijo, Jason Li, Azhar Zahoor Abbasi, Adria Giacca, Oliver Plettenburg, Xiao Yu Wu · 2015 · Diabetes Technology & Therapeutics
  23. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
    2018 · Europe PMC (PubMed Central)
  24. Pramlintide Improved Measures of Glycemic Control and Body Weight in Patients With Type I Diabetes Mellitus Undergoing Continuous Subcutaneous Insulin Infusion Therapy
    Kathrin Herrmann, Juan P. Frías, Steven V. Edelman, Karen Lutz, Kevin Shan, Steven Chen, David G. Maggs, Orville Kolterman · 2013 · Postgraduate Medicine
  25. Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring
    González-Molero, Inmaculada, Domínguez-López, Marta, Guerrero, Mercedes, Carreira, Mónica, Caballero, Felix, Rubio-Martín, Eleazara, Linares, Francisca, Cardona, Isabel, Anarte, Maria Teresa, de Adana, Maria Soledad Ruiz et al. · 2012 · Journal of Telemedicine and Telecare
  26. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort
    Lars Müller, STEPHANIE HABIF, SCOTT A. LEAS, Eliah S. Aronoff-Spencer · 2019 · Diabetes Technology & Therapeutics
  27. Psychosocial Factors and Adherence to Continuous Glucose Monitoring in Type 1 Diabetes
    Signe Schmidt, Anne Katrine Duun‐Henriksen, Kirsten Nørgaard · 2012 · Journal of Diabetes Science and Technology
  28. How has psycho‐behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?
    Christel Hendrieckx, Linda A Gonder-Frederick, Simon R. Heller, Frank Jan Snoek, Jane Speight · 2019 · Diabetic Medicine
  29. Diabetes technology and treatments in the paediatric age group
    Shlomit Shalitin, H. Peter Chase · 2011 · International Journal of Clinical Practice
  30. Cystic Fibrosis–related Diabetes: A First Canadian Clinical Practice Guideline
    Adèle Coriati, Kathryn J. Potter, Julie A. Gilmour, Grace Y. Lam, Carly Nichols, Larry C. Lands, Mary-Anne Doyle, Valérie Boudreau, Laure Alexandre‐Heymann, Martha L. McKinney et al. · 2024 · Canadian Journal of Diabetes
  31. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania
    Lulengo J Mukama, Antoinette Moran, Mramba Nyindo, Rune Nathaniel Philemon, Levina January Msuya · 2012 · Pediatric Diabetes
  32. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)
    Jeremy Pettus, Steven V. Edelman · 2016 · Journal of Diabetes Science and Technology
  33. Transcutaneous Measurement of Essential Vitamins Using Near‐Infrared Fluorescent Single‐Walled Carbon Nanotube Sensors
    Naveed A. Bakh, Xun Gong, Michael A. Lee, Xiaojia Jin, Volodymyr B. Koman, Minkyung Park, Freddy T. Nguyen, Michael S. Strano · 2021 · Small
  34. 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
    Seung‐Hyun Ko · 2021 · Journal of Korean Diabetes
  35. G2OP2C – A Deep Reinforcement Learning Algorithm for Glucose Control by Glucose Prediction and Planning in Type 1 Diabetes
    Chirath Hettiarachchi, Nicolò Malagutti, Christopher James Nolan, Hanna Suominen, Elena Daskalaki · 2022 · Biomedical Signal Processing and Control
  36. Insulin Pump Software Certification
    Yihai Chen, Mark S. Lawford, Hao Wang, Alan Wassyng · 2014 · Lecture notes in computer science
  37. Genetic strategies to bring islet xenotransplantation to the clinic
    Wayne John Hawthorne, Andrew M. Lew, Helen E. Thomas · 2016 · Current Opinion in Organ Transplantation
  38. Closed-loop insulin delivery: current status of diabetes technologies and future prospects
    Waseem Majeed, Hood Thabit · 2018 · Expert Review of Medical Devices
  39. Engineering an orchestrated release avalanche from hydrogels using DNA-nanotechnology
    Ceren Kımna, Oliver Lieleg · 2019 · Journal of Controlled Release
  40. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials
    Peter Alexander Senior, Jeremy Pettus · 2018 · Diabetic Medicine
  41. The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey
    Elena Daskalaki, Anne Parkinson, Nicola Brew‐Sam, Md Zakir Hossain, David Norman O'Neal, Christopher James Nolan, Hanna Suominen · 2022 · Journal of Medical Internet Research
  42. Personalized LSTM-based alarm systems for hypoglycemia and hyperglycemia prevention
    Francesca Dello Iacono, Lalo Magni, Chiara Toffanin · 2023 · Biomedical Signal Processing and Control
  43. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics
    Margaret L. Lawson, Brenda Bradley, Karen McAssey, Cheril L. Clarson, Susan E. Kirsch, Farid H. Mahmud, Jacqueline R. Curtis, Christine Richardson, Jennilea M. Courtney, Tammy Cooper et al. · 2014 · BMC Pediatrics
  44. Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting
    Kirsten Nørgaard, John Shin, John B. Welsh, Hans Jørgen Gjessing · 2015 · Journal of Diabetes Science and Technology
  45. Continuous Glucose Monitoring Adherence
    Martin I. de Bock, Matthew N. Cooper, Adam J. Retterath, Jennifer A. Nicholas, Trang T. Ly, Timothy William Jones, Elizabeth Ann Davis · 2016 · Journal of Diabetes Science and Technology
  46. The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed ™ 670G Hybrid Closed-Loop System
    Toni L. Cordero, Satish K. Garg, Ronald Brazg, Timothy Silleck Bailey, John Shin, Scott W. Lee, FRANCINE RATNER KAUFMAN · 2017 · Diabetes Technology & Therapeutics
  47. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
    Francesca De Ridder, Marieke den Brinker, Christophe E.M. De Block · 2019 · Therapeutic Advances in Endocrinology and Metabolism
  48. Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: A 2‐year Swedish national survey of children and adolescents with type 1 diabetes
    Wersäll, Johan H., Adolfsson, Peter, Forsander, Gun, Hanas, Ragnar · 2022 · Pediatric Diabetes
  49. OpT2mise: A Randomized Controlled Trial to Compare Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 2 Diabetes—Research Design and Methods
    Ronnie Aronson, Ohad Cohen, Ignacio Conget, Sarah Runzis, Javier Castañeda, Simona de Portu, Scott Lee, Yves Reznik, for the OpT2mise Study Group · 2014 · Diabetes Technology & Therapeutics
  50. In Silico Design of Optimal Ratio for Co-Administration of Pramlintide and Insulin in Type 1 Diabetes
    Francesco Micheletto, Chiara Dalla Man, O. Kolterman, E. Chiquette, K. Herrmann, J. Schirra, B. Kovatchev, C. Cobelli · 2013 · Diabetes Technology & Therapeutics
  51. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
    Jesús Moreno-Fernández, Marcos Pazos-Couselo, María González‐Rodríguez, Pedro Rozas, Miguel Delgado‐Rodríguez, Miguel Aguirre, José Manuel García López · 2018 · Endocrinología Diabetes y Nutrición
  52. Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK
    Pratik Choudhary, Simona de Portu, Arcelia Arrieta, Javier Castañeda, Fiona Campbell · 2019 · Diabetic Medicine
  53. Personal Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older
    Nicholas B. Argento, Katherine Nakamura · 2014 · Endocrine Practice
  54. Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update
    Tumminia, Andrea, Sciacca, Laura, Frittitta, Lucia, Squatrito, Sebastiano, Vigneri, Riccardo, Le Moli, Rosario, Tomaselli, Letizia · 2015 · Patient Preference and Adherence
  55. Type 1 diabetes: from the dream of automated insulin delivery to a fully artificial pancreas
    Moshe Phillip, Aaron J. Kowalski, Tadej Battelino · 2024 · Nature Medicine
  56. The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes DiagnosisDiabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups
    Bruce A. Buckingham, Roy W. Beck, Katrina J. Ruedy, Peiyao Cheng, Craig Kollman, STUART ALAN WEINZIMER, Linda Anne DiMeglio, Andrew A. Bremer, Robert H. Slover, Martin Cantwell · 2013 · Diabetes Technology & Therapeutics
  57. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy
    Bartłomiej Matejko, JAN K. SKUPIEN, Sandra Mrozińska, Małgorzata Grzanka, Katarzyna Cyganek, Beata Kieć‐Wilk, Maciej Tadeusz Malecki, Tomasz Klupa · 2014 · Endocrine
  58. Evaluation of a Novel Continuous Glucose Monitoring-Based Method for Mealtime Insulin Dosing—the iBolus —in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Controlled Trial
    Paolo Rossetti, Francisco Javier Ampudia‐Blasco, Alejandro José Laguna Sanz, Ana Revert, Josep Vehı́, Juan Francisco Ascaso, Jorge Bondía · 2012 · Diabetes Technology & Therapeutics
  59. Pharmacotherapy in Type 1 Diabetes
    Angela McGibbon, Cindy Richardson, Cheri Ann Hernandez, John Dornan · 2013 · Canadian Journal of Diabetes
  60. Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden
    JOHAN H. JENDLE, Jayne Smith‐Palmer, Alexis Delbaere, Simona de Portu, Natalie L. Papo, William J. Valentine, Stéphane Roze · 2017 · Diabetes Therapy
  61. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial
    Ilaria Dicembrini, Laura Pala, Mariasmeralda Caliri, Silvia Minardi, Claudia Cosentino, Matteo Monami, Edoardo Mannucci · 2020 · Diabetes Obesity and Metabolism
  62. A Comparison of Internet Monitoring with Continuous Glucose Monitoring in Insulin-Requiring Type 2 Diabetes Mellitus
    Hugh D. Tildesley, Anthony M. Wright, Jeremy H.M. Chan, Adel B. Mazanderani, Stuart A. Ross, Hamish G. Tildesley, Augustine M. Lee, Tricia S. Tang, Adam S. White · 2013 · Canadian Journal of Diabetes · Retracted
  63. Effect of sensor-augmented pump treatment versus multiple daily injections on albuminuria: A 1-year randomized study
    Rosenlund, Signe, Hansen, Tine Willum, Rossing, Peter, Andersen, Steen · 2015 · The Journal of Clinical Endocrinology & Metabolism
  64. Sensor-Augmented Pump Therapy at 36 Months
    Signe Schmidt, Kirsten Nørgaard · 2012 · Diabetes Technology & Therapeutics
  65. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population
    Bratke, Heiko, Margeirsdottir, Hanna D., Assmus, Jörg, Njølstad, Pål R., Skrivarhaug, Torild · 2021 · Diabetes Therapy
  66. Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
    Flavia Urbano, Ilaria Farella, Giacomina Brunetti, Maria Felicia Faienza · 2023 · International Journal of Molecular Sciences
  67. Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes
    Ananthi Anandhakrishnan, Sufyan Hussain · 2024 · Diabetes Obesity and Metabolism
  68. Feasibility of Adjacent Insulin Infusion and Continuous Glucose Monitoring via the Medtronic Combo-Set
    David Norman O'Neal, Sumona Adhya, Alicia Josephine Jenkins, Glenn M. Ward, John B. Welsh, Gayane R. Voskanyan · 2013 · Journal of Diabetes Science and Technology
  69. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Chinese Diabetes Patients: A Multicenter Study
    Jian Zhou, Xiaofeng Lv, Yiming Mu, Xianling Wang, Jing Li, Xingguang Zhang, Jinxiao Wu, Yuqian Bao, Weiping Jia · 2012 · Diabetes Technology & Therapeutics
  70. HypoDE
    Lutz Heinemann, Dorothee Deiss, Norbert Hermanns, Claudia Graham, Matthias Kaltheuner, Andreas Liebl, David A. Price · 2015 · Journal of Diabetes Science and Technology
  71. Diagnosing cystic fibrosis-related diabetes: current methods and challenges
    Bernadette J. Prentice, Shihab Ahmed Hameed, Charles F. Verge, Chee Yee Ooi, Adam Jaffé, John Widger · 2016 · Expert Review of Respiratory Medicine
  72. Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems
    Cosimo Scuffi · 2010 · touchREVIEWS in Endocrinology
  73. Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines
    Anne L. Peters, Andrew Ahmann, Irl B. Hirsch, Jennifer K. Raymond · 2018 · Journal of the Endocrine Society
  74. Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system
    Akira Matsumoto, Hirohito Kuwata, Shinichiro Kimura, Hiroko Matsumoto, Kozue Ochi, Yuki Moro‐oka, Akiko Watanabe, Hironori Yamada, Hitoshi Ishii, Taiki Miyazawa et al. · 2020 · Communications Biology
  75. Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes
    Shital Kamble, Kevin P. Weinfurt, Kevin Alan Schulman, Shelby D. Reed · 2012 · Medical Decision Making
  76. Insight into hypoglycemia in pediatric type 1 diabetes mellitus
    Kimberly E. Sawyer, Venkat S. Renukuntla, Rubina A. Heptulla · 2012 · International Journal of Pediatric Endocrinology
  77. Hypoglycemia in Diabetes
    Philip E. Cryer, Ana María Arbeláez · 2016 · Wiley eBooks
  78. Bringing closed-loop home
    Hood Thabit, Roman Hovorka · 2014 · Current Opinion in Endocrinology Diabetes and Obesity
  79. Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY)
    Takashi Murata, Akio Kuroda, Munehide Matsuhisa, Masao Toyoda, Moritsugu Kimura, Yushi Hirota, Ken Kato, Hideaki Sawaki, Atsuhito Tone, Satoshi Kawashima et al. · 2020 · Journal of Diabetes Science and Technology
  80. Goat Milk Improves Glucose Homeostasis via Enhancement of Hepatic and Skeletal Muscle AMP‐Activated Protein Kinase Activation and Modulation of Gut Microbiota in Streptozocin‐Induced Diabetic Rats
    Wei Liu, Yalin Zhou, Han Sun, Ruijun Li, Yong Qin, Lanlan Yu, Yuhan Chen, Yong Li, Yuwei Tan, Runlong Zhao et al. · 2021 · Molecular Nutrition & Food Research
  81. Artificial intelligence for non-invasive glycaemic-events detection via ECG in a paediatric population: study protocol
    Martina Andellini, Muhammad Salman Haleem, Massimiliano Angelini, Matteo Ritrovato, Riccardo Schiaffini, Ernesto Iadanza, Leandro Pecchia · 2023 · Health and Technology
  82. The Effects of Lowering Nighttime and Breakfast Glucose Levels with Sensor-Augmented Pump Therapy on Hemoglobin A1c Levels in Type 1 Diabetes
    David M. Maahs, H. Peter Chase, Emily Westfall, Robert H. Slover, Suiying Huang, John Shin, FRANCINE RATNER KAUFMAN, Laura L. Pyle, Janet K. Snell‐Bergeon · 2014 · Diabetes Technology & Therapeutics
  83. Glucose monitoring technologies - complementary or competitive? Role of continuous glucose monitoring versus flash glucose monitoring versus self-monitoring of blood glucose
    Jothydev Kesavadev, Lakshmy Ramachandran, Gopika Krishnan · 2017 · Journal of Diabetology
  84. Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study
    Guillermo Edinson Guzmán, Veline Martínez, Julián Yara, Miguel Angel Mina, Juan Sebastián Solarte, Angela M. Victoria‐Castro, Karen Fériz · 2020 · Journal of Diabetes Research
  85. Felix dies natalis, insulin… ceterum autem censeo “beta is better”
    Lorenzo Piemonti · 2021 · Acta Diabetologica
  86. The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes
    Tatsuhiko Urakami · 2023 · Journal of Clinical Medicine
  87. Treatment Modality–Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study
    Hoshina, Sari, Andersen, Gregers S., Jørgensen, Marit E., Ridderstråle, Martin, Vistisen, Dorte, Andersen, Henrik U. · 2018 · Diabetes Technology & Therapeutics
  88. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting
    Philippe Oriot, Michel Paul Hermans · 2022 · Journal of Diabetes and its Complications
  89. Roadmap to the Effective Use of Continuous Glucose Monitoring: Innovation, Investigation, and Implementation
    Richard M. Bergenstal · 2023 · Diabetes Spectrum
  90. Factores asociados con el control glucémico óptimo en pacientes tratados con bomba de insulina y monitorización continua de glucosa en tiempo real
    Ana María Gómez, Ana María Grizales, Angélica Veloza, Alejandro Marín Sánchez, Óscar Múñoz, Martín Rondón · 2013 · Avances en Diabetología
  91. Effect on Glycemic Control by Short- and Long-Term Use of Continuous Glucose Monitoring in Clinical Practice
    J W Anderson, Stig Attvall, Lennart Sternemalm, Aldina Pivodic, Martin Fahlén, Ragnar Hanås, Gunnar Ekeroth, Marcus Lind · 2011 · Journal of Diabetes Science and Technology
  92. Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes
    Alfonso Galderisi, Elise Schlissel Tremblay, Eda Cengiz · 2017 · Current Diabetes Reports
  93. Experiences of Adults With Type 1 Diabetes Using Glucose Sensor–Based Mobile Technology for Glycemic Variability: Qualitative Study
    Marilyn D. Ritholz, Owen Henn, Astrid Atakov-Castillo, Howard A. Wolpert, Stephanie Edwards, Lawrence Fisher, Elena Toschi · 2019 · JMIR Diabetes
  94. Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
    Ilaria Malandrucco, Benedetta Russo, Fabiana Picconi, Marika Menduni, Simona Frontoni · 2020 · International Journal of Molecular Sciences
  95. Diabetology 4.0: Scoping Review of Novel Insights and Possibilities Offered by Digitalization
    Claudia Eberle, Stefanie Stichling, Maxine Löhnert · 2021 · Journal of Medical Internet Research
  96. Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
    Paul‐Martin Holterhus, Jessica Bokelmann, Felix G. Riepe, Bettina Heidtmann, Verena Wagner, Birgit M. Rami-Merhar, Thomas Michael Kapellen, Klemens Raile, Wulf Quester, Reinhard Walter Holl et al. · 2013 · Diabetes Care
  97. Rational Design of Glucose‐Responsive Insulin Using Pharmacokinetic Modeling
    Naveed A. Bakh, Gili Bisker, Michael A. Lee, Xun Gong, Michael S. Strano · 2017 · Advanced Healthcare Materials
  98. Minimally invasive probes for programmed microfluidic delivery of molecules in vivo
    Jordan G. McCall, Jae‐Woong Jeong · 2017 · Current Opinion in Pharmacology
  99. Severe hypoglycemia in youth with T1DM: going, going … but not yet gone
    William V. Tamborlane · 2011 · Pediatric Diabetes
  100. Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 Diabetes
    Irl B. Hirsch, Satish Kumar Garg, Enrico Repetto, Janet K. Snell‐Bergeon, Brian J. Ulmer, Christopher Perkins, Richard M. Bergenstal · 2025 · JAMA Network Open